NASDAQ: QNCXQuince Therapeutics Inc Stock Ownership - Who owns Quince Therapeutics?
Insider buying vs selling
Have Quince Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dirk Thye | CHIEF EXECUTIVE OFFICER | 2024-01-16 | 149,999 | $0.94 | $141.00kBuy |
| Dirk Thye | CHIEF EXECUTIVE OFFICER | 2024-01-16 | 90,531 | $0.55 | $49.79kBuy |
| David Lamond | Director | 2023-12-14 | 22,627 | $1.04 | $23.53kBuy |
| David Lamond | Director | 2023-12-13 | 22,627 | $1.00 | $22.63kBuy |
| David Lamond | Director | 2023-12-12 | 300 | $1.00 | $300.00Buy |
| David Lamond | Director | 2023-12-12 | 22,327 | $1.02 | $22.77kBuy |
| David Lamond | Director | 2023-12-07 | 19,123 | $1.01 | $19.31kBuy |
| David Lamond | Director | 2023-12-06 | 19,123 | $1.02 | $19.51kBuy |
| David Lamond | Director | 2023-12-05 | 19,123 | $1.01 | $19.31kBuy |
| David Lamond | Director | 2023-12-01 | 14,378 | $0.94 | $13.52kBuy |
QNCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when QNCX insiders and whales buy or sell their stock.
QNCX Shareholders
What type of owners hold Quince Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Epiq Capital Group LLC | 52.65% | 22,753,059 | $23.44M | Insider |
| David Lamond | 10.14% | 4,384,096 | $4.52M | Insider |
| Tang Capital Management LLC | 7.45% | 3,220,000 | $3.32M | Institution |
| Pierre Lamond | 6.68% | 2,886,530 | $2.97M | Insider |
| Pfizer Inc | 6.66% | 2,879,973 | $2.97M | Insider |
| Takeda Ventures Inc | 6.20% | 2,679,802 | $2.76M | Insider |
| Stephen S. Dominy | 3.33% | 1,437,674 | $1.48M | Insider |
| Casey Lynch | 2.73% | 1,180,580 | $1.22M | Insider |
| Vanguard Group Inc | 2.25% | 971,801 | $1.00M | Institution |
| Epiq Capital Group LLC | 2.01% | 870,133 | $896.24k | Institution |
QNCX vs Biotech Stocks
Quince Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.